[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100445453":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":26,"responsibleParty":44,"collaborators":7,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":7,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":7,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":29,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Maria Sklodowska-Curie National Research Institute of Oncology","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Patients who underwent POEM","chalasia patients were recruited from a single center. The pre- and postoperative assessments included Eckardt scores, GerdQ questionnaire, high-resolution esophageal manometry, esophagogastroscopy and pH monitoring.",[13],{"name":14,"affiliation":15,"role":16},"Anna Chaber-Ciopińska, PhD","The Maria Sklodowska-Curie National Research Institute of Oncology","PRINCIPAL_INVESTIGATOR",[18,22],{"name":14,"role":19,"phone":20,"phoneExt":7,"email":21},"CONTACT","(+48) 225463044","annachaber@op.pl",{"name":23,"role":19,"phone":24,"phoneExt":7,"email":25},"Aleksandra Budnicka-Borkowicz, MD","(+48) 791000890","aleksandra.budnicka-borkowicz@coi.pl",[27],{"facility":28,"status":29,"city":30,"state":7,"zip":7,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Maria Sklodowska-Curie Institute - Oncology Center","RECRUITING","Warsaw","Poland","PL",{"type":34,"coordinates":35},"Point",[36,37],21.01178,52.22977,{"lat":37,"lon":36},[40,42],{"name":14,"role":19,"phone":41,"phoneExt":7,"email":21},"+48 225463044",{"name":23,"role":19,"phone":43,"phoneExt":7,"email":25},"+48 791000890",{"type":45,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100445453","analysis-of-prevalence-and-risk-factors-associated-with-gastroesophageal-reflux-disease-and-esophagitis-after-peroral-endoscopic-myotomy-100445453",false,"NCT05080634","Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy","Analysis of Incidence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy","Inclusion Criteria:\n\n1. Males and females who are 18 years of age and older and are willing to sign an Informed Consent Form (ICF)\n2. Achalasia patients who underwent POEM\n\nExclusion Criteria:\n\n1. Lack of written consent for participation in the study\n2. Conditions which are contraindication to Esophagogastroscopy and High-resolution Esophageal Manometry","ALL","18 Years",{"count":56,"type":57},100,"ESTIMATED","5 Years","OBSERVATIONAL","Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of the myenteric plexus in the lower esophageal wall. Peroral endoscopic myotomy (POEM) is a minimally invasive procedure capable of overcoming limitations of achalasia treatments. This study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GERD in patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated with post-POEM GERD.",[62,63],"Achalasia","GERD",[65,66],"Peroral endoscopic myotomy","High-resolution esophageal manometry","2021-10-04",{"date":69,"type":70},"2021-10-18","ACTUAL",{"date":72,"type":70},"2021-06-01",{"date":74,"type":57},"2026-09-01",{"name":5,"class":6},1]